Gayle MBA - Bergenbio ASA Chief Officer
Insider
Gayle MBA is Chief Officer of Bergenbio ASA
| Age | 68 |
| Phone | 47 55 96 11 59 |
| Web | https://www.bergenbio.com |
Bergenbio ASA Management Efficiency
The company has return on total asset (ROA) of (0.4939) % which means that it has lost $0.4939 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.9551) %, meaning that it generated substantial loss on money invested by shareholders. Bergenbio ASA's management efficiency ratios could be used to measure how well Bergenbio ASA manages its routine affairs as well as how well it operates its assets and liabilities.Bergenbio ASA has accumulated 942 K in total debt with debt to equity ratio (D/E) of 0.1, which may suggest the company is not taking enough advantage from borrowing. Bergenbio ASA has a current ratio of 8.07, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Bergenbio ASA until it has trouble settling it off, either with new capital or with free cash flow. So, Bergenbio ASA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bergenbio ASA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bergenbio to invest in growth at high rates of return. When we think about Bergenbio ASA's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Tolv Hillestad | Photocure | N/A | |
| Anders Lindblom | XXL ASA | N/A | |
| Harald Borgen | XXL ASA | N/A | |
| Anders Neijber | Photocure | N/A | |
| Kristin Eivindvik | PCI Biotech Holding | 62 | |
| Stein Eriksen | XXL ASA | N/A | |
| Patricia Kelly | Photocure | N/A | |
| Pal Wibe | XXL ASA | 55 | |
| Tolle Groterud | XXL ASA | N/A | |
| Marianne Be | Idex ASA | N/A | |
| Magnus Kreuger | XXL ASA | N/A | |
| Andr Sjst | XXL ASA | N/A | |
| Svein Mathiassen | Idex ASA | N/A | |
| Eileen Wynne | Idex ASA | 57 | |
| David Moskowitz | Photocure | N/A | |
| Pasi Lmps | XXL ASA | N/A | |
| Anders Hgset | PCI Biotech Holding | 69 | |
| Kari MD | Photocure | N/A | |
| Vincent Graziani | Idex ASA | 62 | |
| Geoffrey Coy | Photocure | 53 | |
| Catharina Eklof | Idex ASA | 54 | |
Management Performance
| Return On Equity | -0.96 | |||
| Return On Asset | -0.49 |
Bergenbio ASA Leadership Team
Elected by the shareholders, the Bergenbio ASA's board of directors comprises two types of representatives: Bergenbio ASA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bergenbio. The board's role is to monitor Bergenbio ASA's management team and ensure that shareholders' interests are well served. Bergenbio ASA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bergenbio ASA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rune Skeie, Chief Officer | ||
| Debbie Molyneux, Chief Officer | ||
| Nigel MSc, Chief Officer | ||
| Alison Messom, Director Operations | ||
| James Barnes, Chief Officer | ||
| Cristina MD, Chief Officer | ||
| Martin Olin, Chief Officer | ||
| Gayle MBA, Chief Officer | ||
| Akil Jackson, Medical Director |
Bergenbio Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bergenbio ASA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.96 | |||
| Return On Asset | -0.49 | |||
| Operating Margin | (383.14) % | |||
| Current Valuation | 421.26 M | |||
| Shares Outstanding | 88.66 M | |||
| Shares Owned By Insiders | 34.95 % | |||
| Shares Owned By Institutions | 19.17 % | |||
| Price To Book | 3.92 X | |||
| Price To Sales | 756.59 X | |||
| Revenue | 774 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Bergenbio Stock
Bergenbio ASA financial ratios help investors to determine whether Bergenbio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bergenbio with respect to the benefits of owning Bergenbio ASA security.